Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Nationwide Children's Hospital · with Ohio State University · NCT03622359
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 192
- US sites recruiting
- 1
- Study start
- February 17, 2017
- Record last updated
- October 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower extremities will provide a sensitive non-invasive imaging tool for quantifying regional abnormalities in skeletal muscle perfusion and evaluating responses to medical treatment.
Being studied: SPECT/CT perfusion imaging; PET/CT perfusion imaging
Conditions: Peripheral Artery Disease; Diabetes Mellitus; Chronic Limb-Threatening Ischemia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for Patients with Peripheral Artery Disease:
- At least 18 years of age
- Evidence of significant obstructive disease for one or multiple lower extremity arteries, as identified by prior ABI, TBI, CT angiography, ultrasound, or MR imaging.
Exclusion Criteria for Patients with Peripheral Artery Disease:
- Unable to give informed consent or follow-up
- Pregnant or nursing
- Under the age of 18
- No history of peripheral artery disease
Inclusion Criteria for Healthy Control Subjects:
- At least 18 years of age
- No evidence or prior diagnosis of peripheral artery disease based on chart review and standard vascular screening.
Exclusion Criteria for Healthy Control Subjects:
- Unable to give informed consent of follow-up
- Pregnant or nursing
- Under the age of 18
- History of peripheral artery disease
Recruiting US locations
Nationwide Children's Hospital
Columbus, OH 43205
Site contact: Mitchel R Stacy, Ph.D. · 614-355-5836 · Mitchel.Stacy@nationwidechildrens.org
Study contacts (from the official record)
- Mitchel R Stacy, Ph.D. · 614-355-5836 · Mitchel.Stacy@nationwidechildrens.org
Similar studies in Ohio
All diabetes studies in Ohio →- RecruitingHealthy volunteersEarly Phase 1
Effect of C-peptide on Hypoglycemic Counterregulation
University of Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Columbus, OH + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Canton, OH + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
- Location
- Columbus, OH + 19 other US sites
- Eligibility basics
- Ages 18–75